Thalassaemia trials in Japan

2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 4Enrolling by invitation
  A Study to Provide Access to Mitapivat for Participants Who Previously Participated in an Agios-Sponsored Mitapivat Study

  Where

  Kyoto, Ōta-ku, Sendai

  Age

  18 years and over

  People

  55 worldwide

  Run by

  Agios Pharmaceuticals, Inc.

  See details and how to joinNCT05777993 · EU 2026-526243-35-00
• Phase 3Taking people
  A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

  Where

  Chiba, Himeji, Hitachi, Kamakura, Kamogawa, Matsuyama, Nagasaki, Nagoya, Ōgaki, Osaka, Sagamihara, Sakai, Sendai, Shibuya City, Shinagawa City

  Age

  18 years and over

  People

  665 worldwide

  Run by

  Celgene

  See details and how to joinNCT04064060